ArticleCytometry. Part B, Clinical cytometry2026
To fret over FRET: Unintended fluorescence energy transfer artifacts and their implications for flow cytometry panel design and interpretation as highlighted by TRBC1/2 assays.
Article in Cytometry. Part B, Clinical cytometry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Förster resonance energy transfer (FRET) serves as the fundamental mechanism underlying a wide array of technologies employed in biomedical research and clinical diagnostic applications. However, unintended FRET is often overlooked, despite its potential to introduce assay artifacts that may lead to misinterpretation. Here, we examine the impact of unwanted FRET on clinical flow cytometric testing, focusing on the T-cell assay incorporating TRBC1 and TRBC2, which has emerged as a powerful method for assessing T-cell clonality. We illustrated the effect using a representative case of spurious antigen expression associated with false TRBC restriction and demonstrate through control experiments that this artifact arises when target antigens in close proximity are labeled with fluorochromes having overlapping spectra. We quantified the spectral overlap integral J(λ), and generated a matrix for commonly used fluorochromes, providing a practical tool to identify fluorochrome pairs with a high FRET propensity that should be avoided when labeling closely situated antigens. Overall, recognizing the potential effects of unintended FRET and implementing strategies to prevent or minimize its impact are essential for ensuring accurate interpretation of clinical flow cytometric assays.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.